CHIDSEY JOHN 4

What Happened John Chidsey, a director of HCA Healthcare, reported receiving an award of 809 restricted share units (RSUs) on April 28, 2026. The Form 4 records the acquisition at $0.00 (award grant). Per the filing, the award comprises 509 RSUs from an annual director equity grant and 300 RSUs issued in lieu of an annual cash retainer. The RSUs vest on the earlier of the 2027 annual shareholders’ meeting or the first anniversary of the grant.

Key Details

• Transaction date: 2026-04-28; Form 4 filed 2026-04-30.
• Transaction type/code: Award/Grant (A); reported acquisition price: $0.00.
• Award breakdown: 509 RSUs (annual equity award) + 300 RSUs (in lieu of cash retainer) = 809 RSUs.
• Vesting: Vest on sooner of 2027 annual meeting or one year from grant.
• Shares owned after transaction: Not specified in the Form 4.
• Footnote on ownership: The reported shares are held in a fully managed account over which Chidsey has no investment authority; he disclaims beneficial ownership except for any pecuniary interest (per F2).
• Filing timeliness: Filed within two business days of the transaction (not marked late).

Context This is an equity award to a board member rather than an open-market purchase or sale. RSUs convert to common shares upon vesting and will have market value at that time; the Form 4 records the grant itself at $0 because no cash was exchanged. Awards to directors are common compensation practices and do not, by themselves, indicate the director is buying or selling shares on a market signal.